Johnson & Johnson (NYSE: JNJ) stock has declined 2% since the beginning of this year (through April 8), compared to a 15% decline for the broader S&P 500. Despite this outperformance, we believe that Johnson & Johnson’s stock has a significant upside from the current levels of around $140...
